CLOs on the Move

Galderma Laboratories, L.P.

www.galderma.com

 
Galderma Laboratories, L.P. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Fort Worth, TX. To find more information about Galderma Laboratories, L.P., please visit www.galderma.com
  • Number of Employees: 25-100
  • Annual Revenue: > $1 Billion
  • www.galderma.com
  • 14501 North Fwy
    Fort Worth, TX USA 76177-3304
  • Phone: 817.961.5000

Executives

Name Title Contact Details
Devon Sharp
Associate General Counsel Profile
Grant Riedesel
Head of Legal, Corporate Development Profile
Tim Stow
Global Head of Ethics and Compliance Profile
Sean Griffin
Vice President of Regulatory Affairs Profile

Similar Companies

Pain Treatment Centers of America

Pain Treatment Centers of America is a comprehensive pain management clinic that offers both opioid and non-opioid medical management, as well as an array of minimally invasive pain management techniques.

Citicorp Vendor Finance

Citicorp Vendor Finance is a Mount Laurel, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CareSync

Founded in 2011, CareSync is the leading provider of software and services for chronic disease management, combining technology with 24/7 nursing services to facilitate care coordination among patients, family and caregivers and all providers. CareSync provides turnkey Chronic Care Management services as well as a software-only option, allowing practices of any size to easily meet the billing requirements for CPT code 99490. Additionally, CareSync`s certified technology makes it simple for providers to meet Meaningful Use 2 for Data Exchange, Messaging and Timely Access. CareSync patients are at the center of their healthcare, with access to health information, actionable goals, and Comprehensive Care Plan tasks. As a result, CareSync`s patients are experiencing more productive medical appointments and better health outcomes.

Imagin Medical

Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin`s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.

Schnepp Nursing Home

Schnepp Health Care Center is deeply committed to providing the highest quality rehabilitation services. Our facility offers a full-time physical therapist with full-time assistants and specially trained restorative nursing staff that continues to work